Annual report pursuant to Section 13 and 15(d)

Acquisitions

v3.19.3
Acquisitions
12 Months Ended
Dec. 31, 2018
Business Combinations [Abstract]  
Acquisitions

Note 6 – Acquisitions

 

Purchase Agreement Re Jamestown Regional Medical Center

 

On June 1, 2018, the Company acquired a business engaging in acute hospital care located in Jamestown, Tennessee under an asset purchase agreement. The acquisition also included a separate physician practice which now operates under the Company as Mountain View Physician Practice, Inc. This acquisition was made as part of the Company’s business plan to acquire and operate clusters of rural hospitals.

 

Pursuant to the asset purchase agreement, by and among the Company and Jamestown TN Medical Center, Inc., and HMA Fentress County Hospital, LLC, Jamestown HMA Physician Management, LLC and CHS/Community Health Systems, Inc. (the “Sellers”), the purchase price paid for the transaction was $635,096.

 

The fair value of the purchase consideration paid to the Sellers was allocated to the net tangible and intangible assets acquired. The Company accounted for the acquisition as a business combination under U.S. GAAP. In accordance with the acquisition method of accounting under ASC Topic 805, “Business Combinations,” (“ASC 805”) the assets acquired, and liabilities assumed were recorded as of the acquisition date, at their respective fair values and consolidated with those of the Company.

 

The fair value of the assets acquired, net of the liabilities assumed, was approximately $8.2 million. The excess of the aggregate fair value of the net tangible assets acquired over the purchase price was estimated to be $7.6 million and has been treated as a gain on bargain purchase in accordance with ASC 805. We attribute the gain primarily to the value of the land and building acquired. The purchase price allocation was based, in part, on our management’s knowledge of HMA Fentress County General Hospital and Jamestown HMA Physician Management, LLC.

 

The following table shows the allocation of the purchase price of Jamestown Regional Medical Center to the acquired identifiable assets acquired, and liabilities assumed:

 

 

Total purchase price   $ 635,096  
Tangible and intangible assets acquired, and liabilities assumed at estimated fair value:        
Cash   $ 375  
Inventories     450,682  
Prepaids and deposits     310,385  
Property and equipment     7,129,484  
Intangible assets     504,806  
Accrued expenses     (193,966 )
Net tangible and intangible assets acquired   $ 8,201,766  
Gain on bargain purchase   $ 7,566,670  

 

The total cost relating to the acquisition was approximately $1,100,000. This includes $635,096, which includes closing costs of $35,735, legal costs of approximately $115,000, and other diligence related costs, which were expensed in 2018.

 

The intangible assets acquired in the Jamestown acquisition consisted of the following at December 31, 2018:

 

   

Acquired in

2018

    Life  

Impairment in

2018

   

Amortization for the
Year Ended

December 31, 2018

   

Carrying Value

December 31, 2018

 
Certificate of need   $ 259,443     Infinite   $ -     $ -     $ 259,443  
Non-compete     245,363     2 yrs.     (173,799 )     (71,564 )     -  
Total intangibles   $ 504,806         $ (173,799 )   $ (71,564 )   $ 259,443  

 

As noted in the table above, we fully impaired the non-compete intangible asset acquired in the acquisition of Jamestown Regional Medical Center at December 31, 2018. We determined that this asset was impaired primarily due to the operating results of Jamestown Regional Medical Center since the acquisition on June 1, 2018, which were as follows:

 

   

For the Period

June 1, 2018
to

December 31, 2018
(unaudited)

 
Net Revenue   $ 7,898,222  
Net Loss   $ (2,022,380 )

 

The following presents the unaudited pro-forma combined results of operations of the Company and Jamestown Regional Medical Center as if the acquisition had occurred on January 1, 2017.

 

    Year Ended  
    December 31,  
    2018     2017  
    (unaudited)  
Net revenue   $ 19,983,266     $ 19,446,732  
Net loss from continuing operations     (15,720,672 )     (55,305,325 )
Net loss     (16,155,515 )     (59,582,243 )
Deemed dividend from trigger of down round provision feature     (231,843,826 )     (53,341,619 )
Net loss to common stockholders   $ (247,999,341 )   $ (112,923,862 )
                 
Net loss per common share:                
Basic and diluted continuing operations   $ (24.70 )   $ (23,537.03 )
Basic and diluted net loss to common stockholders   $ (24.75 )   $ (24,463.57 )

 

The unaudited pro-forma results of operations are presented for information purposes only. The unaudited pro-forma results of operations are not intended to present actual results that would have been attained had the acquisition been completed as of January 1, 2017 or to project potential operating results as of any future date or for any future periods.